Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
CB1 agonist, TRPV1 agonist.
Endogenous RF-amide peptide, involved in nocice...
Non-selective CB receptor agonist.
Smoothened agonist.
NSAID; TRPA1 agonist, COX-2 inhibitor.
Bisphosphonate; inhibits transfer of farnesyl p...
Recombinant protein containing Treponema pallid...
CDK1/2 inhibitor.
Alpha blocker and vasoactive agent.
ROCK1/2 inhibitor, potential RSK and p70S6K inh...
Alters membrane permeability and Ca2+ signaling...
α-glucosidase inhibitor.
PI3K inhibitor.
Natural steroid hormone produced by arthropods;...
Diterpene found in brewed, unfiltered coffee; F...
Calcium channel blocker.
Oligodendrocyte antigen used to induce EAE.
Arylbenzimidazole; CHK2 inhibitor.
Phytohormone
DP1 antagonist.